Arbutus Biopharma Corporation ABUS Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on the most recent quarter.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's cash ratio?
- Arbutus Biopharma Corporation (ABUS) reported cash ratio of 4.6× in Q1 2026.
- How has Arbutus Biopharma Corporation's cash ratio changed year-over-year?
- Arbutus Biopharma Corporation's cash ratio increased by 143.4% year-over-year, from 1.9× to 4.6×.
- What is the long-term trend for Arbutus Biopharma Corporation's cash ratio?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's cash ratio has grown at a -11.4% compound annual growth rate (CAGR), from 5.5× to 3×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.